VIR 8-K 2026-10-01

Vir Biotechnology, Inc. (VIR) 8-K dated 2026-10-01 — accession 0001628280-26-064117. This URL is the filing, not the VIR hub.

Vir Biotechnology, Inc. (VIR) is a biotechnology company listed on NASDAQ.

Vir Biotechnology, Inc. filed a 8-K on 2026-10-01. Accession 0001628280-26-064117.

Cached items: 5.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported VIR revenue for 2025-12-31 was $68.6M. Net income was -$438.0M. Revenue was down 7.6% from 2024-12-31 to 2025-12-31. VIR currently screens at market cap $1.45B.

Not investment advice. The VIR SEC hub lists recent forms. The stock page is the research view.